AIDS-ONCOLOGY CLINICAL SCIENTIST DEVELOPMENT PROGRAM

艾滋病肿瘤学临床科学家发展计划

基本信息

  • 批准号:
    6173645
  • 负责人:
  • 金额:
    $ 33.61万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-08-11 至 2002-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION: (Applicant's Description) As survival has increased in patients with HIV infection, it is apparent that greater numbers of individuals are living long enough to eventually develop malignant disease. Further, with maturation of the AIDS epidemic, it appears that the spectrum of HIV associated diseases has expanded, with malignant diseases becoming more prominent as the cause of death in infected individuals. Aside from the current AIDS-defining malignancies, including Kaposi's sarcoma, lymphoma, and cervical cancer, additional types of cancers are now being reported in HIV infected individuals, with significantly increased standardized incidence ratios (SIRs) of anal cancer, Hodgkin's disease, lung cancer, multiple myeloma and others. In terms of public health policy, it is apparent from these data that the appropriate health care of our nation will require specific training of oncologist in the area of HIV disease. At the present time, there is no formalized mechanism to provide such cross-training, nor is there a mechanism to pay for such training. The goals of this Training Grant will be to train such individuals, who will then be prepared to treat HIV infected patients with malignant disease; to conduct research in this area; and, in time, to teach others these same skills. The specific aims of the proposal are: (1) To provide comprehensive, multidisciplinary clinical training in HIV disease to individuals who have recently completed one or more years of formal fellowship training in Hematology'/Oncology; (2) To provide a didactic core curriculum, which will give a broad understanding of the advances in HIV disease, per se, as well as the opportunistic cancers, infections, and other illnesses which ensue; (3) To provide a didactic core curriculum, as well as practical, day-to-day training in the area of clinical research methods, to allow development of future clinical researchers in the area of AIDS-related malignancy; (4) To provide didactic training in the area of basic scientific research methods, to allow development of future clinical researchers who will understand the principles of translational research in the area of AIDS-malignancy; and (5) To provide close mentoring support from both clinical and basic scientific mentors, in order to assure that the candidates will engage in a specific translational research project related to the field of HIV-malignancies. We will offer a two-year Fellowship program. The first year will be spent in clinical work, with assignment of a specific clinical mentor to each Trainee. The year will consist of attendance at weekly general HIV/AIDS clinic; weekly AIDS/Lymphoma clinic; weekly AIDS/KS clinic; one month on in-patient HIV/AIDS ward; three months on inpatient AIDS malignancy ward; and attendance at didactic lectures and symposia. The second year will emphasize training in clinical and translational research in the area of AIDS-related malignancy, with assignment of specific scientific mentors, and development of research projects, as well as attendance at didactic lectures and symposia in the area of research methods and biologic principles.
描述:(申请人描述)随着生存的增加

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

ALEXANDRA M LEVINE其他文献

ALEXANDRA M LEVINE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('ALEXANDRA M LEVINE', 18)}}的其他基金

A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS)
EPOCH 的随机 II 期试验(艾滋病)
  • 批准号:
    7716685
  • 财政年份:
    2008
  • 资助金额:
    $ 33.61万
  • 项目类别:
A PHASE I STUDY OF VEGF- ANTISENSE OLIGONUCLEOTIDE (VEGF-AS) GIVEN AS A DAILY
每日给予 VEGF 反义寡核苷酸 (VEGF-AS) 的 I 期研究
  • 批准号:
    7716712
  • 财政年份:
    2008
  • 资助金额:
    $ 33.61万
  • 项目类别:
University of Southern California
南加州大学
  • 批准号:
    7130726
  • 财政年份:
    2006
  • 资助金额:
    $ 33.61万
  • 项目类别:
A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS)
EPOCH 的随机 II 期试验(艾滋病)
  • 批准号:
    7603909
  • 财政年份:
    2006
  • 资助金额:
    $ 33.61万
  • 项目类别:
A PHASE I STUDY OF VEGF- ANTISENSE OLIGONUCLEOTIDE (VEGF-AS) GIVEN AS A DAILY
每日给予 VEGF 反义寡核苷酸 (VEGF-AS) 的 I 期研究
  • 批准号:
    7603936
  • 财政年份:
    2006
  • 资助金额:
    $ 33.61万
  • 项目类别:
A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS)
EPOCH 的随机 II 期试验(艾滋病)
  • 批准号:
    7368206
  • 财政年份:
    2005
  • 资助金额:
    $ 33.61万
  • 项目类别:
A RANDOMIZED PHASE II TRIAL OF EPOCH (AIDS)
EPOCH 的随机 II 期试验(艾滋病)
  • 批准号:
    7200017
  • 财政年份:
    2004
  • 资助金额:
    $ 33.61万
  • 项目类别:
A RANDOMIZED PHASE II TRIAL OF EPOCH
EPOCH 的随机 II 期试验
  • 批准号:
    7040188
  • 财政年份:
    2003
  • 资助金额:
    $ 33.61万
  • 项目类别:
AMC 005--CHOP & TRIPLE ANTIRETROVIRAL IN AIDS RELATED NON HODGKINS
AMC 005--斩波
  • 批准号:
    6421159
  • 财政年份:
    2000
  • 资助金额:
    $ 33.61万
  • 项目类别:
AMC 005--CHOP & TRIPLE ANTIRETROVIRAL IN AIDS RELATED NON HODGKINS
AMC 005--斩波
  • 批准号:
    6263762
  • 财政年份:
    1998
  • 资助金额:
    $ 33.61万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了